Re: Androgen-Deprivation Therapy Alone or with Docetaxel in Non-Castrate Metastatic Prostate Cancer (GETUG-AFU 15): A Randomised, Open-Label, Phase 3 Trial

Samir Taneja

doi:10.1016/j.juro.2013.08.104

Re: Androgen-Deprivation Therapy Alone or with Docetaxel in Non-Castrate Metastatic Prostate Cancer (GETUG-AFU 15): A Randomised, Open-Label, Phase 3 Trial

Samir Taneja

Biomedical Engineering

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Journal	The Journal of Urology
DOIs	https://doi.org/10.1016/j.juro.2013.08.104
State	Published - 2013

Access to Document

10.1016/j.juro.2013.08.104

Cite this

@article{51d75f4e91a34046aa8bcd854ea8f2a8,

title = "Re: Androgen-Deprivation Therapy Alone or with Docetaxel in Non-Castrate Metastatic Prostate Cancer (GETUG-AFU 15): A Randomised, Open-Label, Phase 3 Trial",

author = "Samir Taneja",

year = "2013",

doi = "10.1016/j.juro.2013.08.104",

language = "English (US)",

journal = "The Journal of Urology",

issn = "0022-5347",

}